Evaluating Selected Constituents in the Exhaled Breath Samples

NACompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

October 3, 2019

Primary Completion Date

December 12, 2019

Study Completion Date

December 13, 2019

Conditions
Electronic Cigarette UseCigarette Use, ElectronicTobacco UseTobacco Smoking
Interventions
OTHER

JUUL ENDS 5% Virginia Tobacco

JUUL ENDS Virginia Tobacco 5% nicotine strength

OTHER

JUUL 3% Virginia Tobacco ENDS

JUUL ENDS Virginia Tobacco 3% nicotine strength

OTHER

JUUL 5% Mint ENDS

JUUL ENDS Mint 5% nicotine strength

OTHER

JUUL 3% Mint ENDS

JUUL ENDS Mint 3% nicotine strength

OTHER

JUUL 5% Menthol ENDS

JUUL ENDS Menthol 5% nicotine strength

OTHER

JUUL 3% Menthol ENDS

JUUL ENDS Menthol 3% nicotine strength

OTHER

JUUL 5% Mango ENDS

JUUL ENDS Mango 5% nicotine strength

OTHER

JUUL 3% Mango ENDS

JUUL ENDS Mango 3% nicotine strength

OTHER

US Cigarette, Non-menthol - Marlboro Gold King Size

US Cigarette, Non-menthol - Marlboro Gold King Size

OTHER

US Cigarette, Menthol - Newport King Size

US Cigarette, Menthol - Newport King Size

Trial Locations (3)

27617

Rose Research Center, Raleigh

28262

Rose Research Center, Charlotte

07094

Frontage Clinical Services, Secaucus

All Listed Sponsors
lead

Juul Labs, Inc.

INDUSTRY

NCT04143256 - Evaluating Selected Constituents in the Exhaled Breath Samples | Biotech Hunter | Biotech Hunter